VAI-SU2C Epigenetics Dream Team
38 results.
LOS ANGELES, August 16, 2018 – Stand Up To Cancer (SU2C), a division of the Entertainment Industry Foundation (EIF), is proud to…
Part three: What we’re doing to move lab discoveries into the clinic
In the past few weeks, VAI Voice has discussed what it takes to translate a promising laboratory discovery into a life-changing, approved treatment. In our…
Part two: Before a new medication can be used in patients, it must go through a gauntlet of tests to ensure it is safe and effective
In the second installment in our multi-part series on how a new medication moves from the lab to the doctor’s office, we take a look…
LOS ANGELES (June 5, 2018) — The entertainment community is coming together for Stand Up To Cancer (SU2C) and its sixth biennial roadblock televised fundraising special,…
Four years ago, we embarked on a collaborative endeavor to improve cancer treatment by establishing the Van Andel Research Institute–Stand Up To Cancer (VARI–SU2C) Epigenetics…
With 2017 quickly coming to close, we’d like to reflect on all that’s been accomplished by rounding up some of this year’s most notable stories…
A first-of-its-kind combination of medications may enable the immune system to better combat lung cancer, which claims more lives than any other cancer type and…
Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers
By Dr. Peter Jones and Dr. Steve Baylin
…